Share-Based Compensation (Tables)

9 Months Ended

Nov. 02, 2013

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Assumptions used to Compute Share-Based Compensation Expense

The following table shows the Company’s assumptions used to compute the share-based compensation expense:

	Stock Option Plans Thirty-nine weeks ended							Stock Purchase Plan Thirty-nine weeks ended
	November 2,			October 27,			November 2,			October 27,
	2013			2012			2013			2012
Weighted-average risk free rate of interest		1.02	%		1.50	%		0.17	%		0.22	%
Expected volatility		42	%		43	%		40	%		38	%
Weighted-average expected award life		6.0 years			5.5 years			1.0 year			1.0 year
Dividend yield		2.3	%		2.3	%		2.3	%		2.5	%
Weighted-average fair value	$	10.98		$	10.12		$	5.80		$	5.91

Options Granted under Stock Option Plans

The information in the following table covers options granted under the Company’s stock option plans for the thirty-nine weeks ended November 2, 2013:

(in thousands, except price per share and weighted-average term)	Shares		Weighted- Average Term	Weighted- Average Exercise Price
Options outstanding at the beginning of the year		5,907		$	19.93
Granted		1,154			34.25
Exercised		(964)			19.12
Expired or cancelled		(59)			29.56
Options outstanding at November 2, 2013		6,038	6.59	$	22.70
Options exercisable at November 2, 2013		3,857	5.40	$	18.51
Options available for future grant at November 2, 2013		3,336

Aggregate Intrinsic Value for Stock Options Outstanding and Exercisable

	Thirteen weeks ended				Thirty-nine weeks ended
	November 2,		October 27,		November 2,		October 27,
Intrinsic value of stock options (in millions)	2013		2012		2013		2012
Exercised	$	2	$	9	$	15	$	24
Outstanding					$	74	$	85
Outstanding and exercisable					$	64	$	61

Information about Stock Options Outstanding and Exercisable

The following table summarizes information about stock options outstanding and exercisable at November 2, 2013:

				Options Outstanding				Options Exercisable
Range of Exercise Prices				Number Outstanding	Weighted- Average Remaining Contractual Life	Weighted- Average Exercise Price		Number Exercisable	Weighted- Average Exercise Price
(in thousands, except price per share and contractual life)
$	9.85	$	15.10	1,756	5.86	$	12.60	1,756	$	12.60
$	15.74	$	23.42	1,603	6.36	$	19.71	1,156	$	20.04
$	23.63	$	30.92	1,540	5.61	$	28.77	937	$	27.55
$	31.79	$	36.59	1,139	9.36	$	34.26	8	$	34.17
$	9.85	$	36.59	6,038	6.59	$	22.70	3,857	$	18.51

Changes in Nonvested Options

Changes in the Company’s nonvested options for the thirty-nine weeks ended November 2, 2013 are summarized as follows:

(in thousands, except price per share)	Number of Shares	Weighted- Average Grant Date Fair Value per Share
Nonvested at the beginning of the year	2,314	$	23.18
Granted	1,154		34.25
Vested	(1,228)		20.97
Expired or cancelled	(59)		29.56
Nonvested at November 2, 2013	2,181	$	30.11

Restricted Shares and Units Activity

Restricted share and unit activity for the thirty-nine weeks ended November 2, 2013 and October 27, 2012 is summarized as follows:

	Number of Shares and Units
(in thousands)	November 2, 2013		October 27, 2012
Outstanding at beginning of period		1,564		2,068
Granted		440		264
Vested		(649)		(482)
Cancelled or forfeited		(15)		—
Outstanding at end of period		1,340		1,850
Aggregate value (in millions)	$	36	$	33
Weighted-average remaining contractual life		1.09 years		0.95 years